Risk of Hypoglycemia: While GLP-1 medications are not typically associated with an increased risk of hypoglycemia when used as monotherapy, they may potentiate the effects of other antidiabetic medications that can cause hypoglycemia, such as sulfonylureas or insulin
GLP-1: What it is GLP-1 is a hormone produced by select cells located in your gut
We aim to comprehensively evaluate the relevance of GLP-1 in headache and pain disorders
Background: How GLP-1s evolved from diabetes treatment to anti-obesity medications Glucagon-like peptide-1 receptor agonists (GLP-1s) have a notable history in medical treatment, beginning as therapies for type 2 diabetes and later emerging as highly effective agents for weight loss
And additionally, she extends her expertise to support fellow doctors in cultivating their online practices, helping them transition away from an insurance-centric model to reclaim their time, financial stability, and freedom